NCT00887809: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes |
|
|
| Completed | 2 | 47 | US | gemcitabine, docetaxel, bevacizumab | Memorial Sloan Kettering Cancer Center, Genentech, Inc. | Sarcoma, Leiomyosarcoma, Malignant Fibrous, Histiocytoma, Angiosarcoma | 10/14 | 11/14 | | |